In colorectal cancer, the anticancer effect of RA causes the inhibition of COX-2 activation by repression of binding of activator protein-1 (AP-1) and c-Fos inducing agents (Hossan et al., 2014). This evidence concerns the gene FOS and colorectal cancer.